Valuation: DiaSorin S.p.A.

Capitalization 3.24B 3.77B 3.04B 2.83B 5.23B 339B 5.69B 35.51B 13.71B 160B 14.15B 13.85B 586B P/E ratio 2025 *
17.8x
P/E ratio 2026 * 14.9x
Enterprise value 3.77B 4.39B 3.54B 3.29B 6.09B 395B 6.62B 41.35B 15.97B 187B 16.48B 16.12B 682B EV / Sales 2025 *
3.09x
EV / Sales 2026 * 2.77x
Free-Float
37.75%
Yield 2025 *
1.95%
Yield 2026 * 2.15%
More valuation ratios * Estimated data
Dynamic Chart
1 day+3.60%
1 week+0.74%
Current month+0.74%
1 month-16.19%
3 months-24.41%
6 months-31.65%
Current year-37.48%
More quotes
1 week 59.98
Extreme 59.98
62.58
1 month 58.18
Extreme 58.18
66.74
Current year 58.18
Extreme 58.18
107.45
1 year 58.18
Extreme 58.18
107.45
3 years 58.18
Extreme 58.18
140.45
5 years 58.18
Extreme 58.18
208.8
10 years 41.66
Extreme 41.66
211.8
More quotes
Manager TitleAgeSince
Chief Executive Officer 59 2007-03-25
Director of Finance/CFO 54 2015-12-31
Corporate Officer/Principal 62 2022-04-28
Director TitleAgeSince
Director/Board Member 59 2016-04-27
Director/Board Member 62 2007-03-25
Chairman 56 2022-04-28
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+3.60%+0.74%-40.58%-53.10% 3.78B
+0.58%-2.87%+7.32%+7.09% 14.35B
-5.26%-5.03%+177.47%+98.21% 13.98B
+1.15%+12.67% - - 7.99B
+0.10%+2.73%-12.73%+22.94% 6.65B
+2.72%+7.81%-28.96%+13.32% 4.1B
+0.64%-1.63%-20.39%-39.48% 2.9B
+0.37%-1.30%-3.43%-30.92% 2.42B
-3.88%-1.40%+225.58%+74.34% 2.26B
-3.44%-6.94%+14.94%-52.13% 2.3B
Average -0.34%+0.52%+35.47%+4.47% 6.07B
Weighted average by Cap. -0.73%+0.72%+51.31%+25.41%
See all sector performances

Financials

2025 *2026 *
Net sales 1.22B 1.42B 1.14B 1.07B 1.97B 128B 2.14B 13.38B 5.17B 60.38B 5.33B 5.22B 221B 1.3B 1.52B 1.22B 1.14B 2.1B 136B 2.28B 14.27B 5.51B 64.4B 5.69B 5.56B 235B
Net income 186M 217M 175M 163M 301M 19.51B 327M 2.04B 788M 9.21B 814M 796M 33.69B 218M 253M 204M 190M 351M 22.81B 382M 2.39B 922M 10.77B 951M 931M 39.38B
Net Debt 533M 620M 499M 465M 859M 55.77B 934M 5.84B 2.25B 26.34B 2.33B 2.28B 96.31B 364M 424M 341M 318M 588M 38.15B 639M 3.99B 1.54B 18.02B 1.59B 1.56B 65.88B
More financial data * Estimated data
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2024, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Employees
3,279
More about the company
Date Price Change Volume
25-12-05 62.24 +3.60% 427,409
25-12-04 60.08 -0.56% 222,199
25-12-03 60.42 -1.27% 237,351
25-12-02 61.20 -0.20% 214,180
25-12-01 61.32 -0.74% 266,746

Real-time Borsa Italiana, December 05, 2025 at 11:45 am EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
60.08EUR
Average target price
92.50EUR
Spread / Average Target
+53.96%
Consensus

Quarterly revenue - Rate of surprise